Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Community pharmacy services

Pharmacy teams may not spot sepsis under new consultation scheme, warns pharmacy negotiator

Alastair Buxton, director of NHS services at the Pharmaceutical Services Negotiating Committee, said pharmacies should take up sepsis training as part of the new pharmacy quality scheme. 

There is a “significant risk” that pharmacy teams will fail to spot sepsis in patients presenting under the new community pharmacist consultation scheme (CPCS) due to begin at the end of October 2019, a pharmacy negotiator has said.

Alastair Buxton, director of NHS services at the Pharmaceutical Services Negotiating Committee, said pharmacists should ensure that they undertake training on how to spot the signs of sepsis and cascade this to their teams to make certain that they are able to refer patients who may be at risk.

Patients will be referred to pharmacists via NHS 111 for some minor illnesses and conditions when the CPCS goes live on 29 October 2019.

Speaking at The Pharmacy Show, held in Birmingham on 5–6 October 2019, Buxton advised pharmacists to note new requirements in the pharmacy quality scheme (PQS) — a rebranded version of the quality payments scheme (QPS) which has also been introduced as part of the CPCS. The PQS is voluntary, but if pharmacies meet certain quality criteria, they must complete online training and carry out a risk review to ensure they are minimising any risk of missing cases of suspected sepsis. 

“There is a new requirement around [Centre for Pharmacy Postgraduate Education (CPPE)] sepsis training and cascading the learning from that to your frontline staff, so they know what the signs and symptoms of sepsis are and they know to refer immediately to a pharmacist,” Buxton said. 

“The risk of us having people referred to us with signs of sepsis and us not spotting it in pharmacy is a significant risk that we don’t want to happen. So focus on that. Another requirement is making a new entry in your risk review relating to spotting the signs of sepsis.” 

The NHS says data on the incidence and prevalence of sepsis is difficult to record, but it adds that, in 2017/2018, hospital admission figures show that there were 186,000 hospital admissions for patients with a primary diagnosis of sepsis, and Office for National Statistics data show that, in 2015, 23,135 people died from sepsis.

Symptoms of sepsis include mottled or ashen skin; cyanosis of the skin, lips or tongue; or a non-blanching skin rash.

Under the PQS, pharmacies will also be required to carry out new training from CPPE on ‘look-alike’ and ‘sound-alike’ errors.



Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207168

Readers' comments (1)

  • Michael Achiampong

    I must say it was refreshing to attend a recent CPPE workshop focused on sepsis and meningitis in Dudley, West Midlands on Saturday 30th November 2019.
    The two GP trainers and the two CPPE tutors etc facilitated the 48 participants in a practical, hands-on manner.
    More of this type of real-world learning please.

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.